APL was acquired by KBI Biopharma, a leading global CDMO, in June 2017. Since the acquisition, APL has continued to provide the high-quality analytical services it has offered since its founding in 1998. We look forward to expanding current client relationships, and building new ones, as part of KBI Biopharma.

Please contact us below to learn more about how we, as part of KBI, can partner with you to support your analytical needs.

We do more than just proteins...

Our biophysical characterization techniques have applications to small peptides, nucleic acids (e.g. anti-sense therapeutics, aptamers, ribozymes), small molecule drugs, carbohydrates, vaccines, viruses, drug-polymer conjugates, and more.

APL offers contract research services in the areas of protein and peptide biophysical characterization, protein aggregation, protein purification, and protein stabilization.


If you are looking for analytical ultracentrifugation (AUC)circular dichroismlight scatteringDSC, fluorescence, or native gel analysis of your biotech product, or help with your protein aggregation problems, you have found the right place!


We have now done such analysis on literally hundreds of products, giving our scientists unparalleled experience.

Contact Us